The US Food and Drug Administration announced Tuesday that it temporarily stayed the marketing denial order it placed on Juul Labs for the company's products in the US.
This means that Juul products will continue to stay on the market while the FDA considers "scientific issues unique to the JUUL application that warrant additional review." The agency noted that it isn't rescinding its order and that all vaping or nicotine-delivery products are still required to have FDA authorization to stay on the US market.
Last month, the FDA denied Juul authorization and the company was ordered to stop selling and distributing its e-cigarettes and pens as well as its tobacco and menthol-flavored pods in the US. But a federal appeals court issued a temporary stay on the ban shortly after it was issued, and the block hasn't been enforced.
Related Coverage
AllSides Picks
Youth Voices
State Mandates Capping Insulin Costs: A Help or Hindrance?
The Alliance for Civic Engagement
June 15th, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
Affordable Care Act